MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/pim.12784

Медицинская библиотека · Parasite immunology · 2020

Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.

Pereira Isabela A G, Mendonça Débora V C, Tavares Grasiele S V, Lage Daniela P, Ramos Fernanda F, Oliveira-da-Silva João A, Antinarelli Luciana M R, Machado Amanda S, Carvalho Lívia M, Carvalho Ana Maria R S, Salustiano Iorrana V, Reis Thiago A R, Bandeira Raquel S, Silva Alessandra M, Martins Vívian T, Chávez-Fumagalli Miguel A, Humbert Maria V, Roatt Bruno M, Duarte Mariana C, Menezes-Souza Daniel, Coimbra Elaine S, Leite João Paulo V, Coelho Eduardo A F, Gonçalves Denise U

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

AIMS: Treatment for visceral leishmaniasis (VL) is hampered by the toxicity and/or high cost of drugs, as well as by emergence of parasite resistance. Therefore, there is an urgent need for new antileishmanial agents.

METHODS AND

RESULTS

In this study, the antileishmanial activity of a diprenylated flavonoid called 5,7,3,4'-tetrahydroxy-6,8-diprenylisoflavone (CMt) was tested against Leishmania infantum and L amazonensis species. Results showed that CMt presented selectivity index (SI) of 70.0 and 165.0 against L infantum and L amazonensis promastigotes, respectively, and of 181.9 and 397.8 against respective axenic amastigotes. Amphotericin B (AmpB) showed lower SI values of 9.1 and 11.1 against L infantum and L amazonensis promastigotes, respectively, and of 12.5 and 14.3 against amastigotes, respectively. CMt was effective in the treatment of infected macrophages and caused alterations in the parasite mitochondria. L infantum-infected mice treated with miltefosine, CMt alone or incorporated in polymeric micelles (CMt/Mic) presented significant reductions in the parasite load in distinct organs, when compared to the control groups. An antileishmanial Th1-type cellular and humoral immune response were developed one and 15 days after treatment, with CMt/Mic-treated mice presenting a better protective response.

CONCLUSION

Our data suggest that CMt/Mic could be evaluated as a chemotherapeutic agent against VL.

Для цитирования: Pereira Isabela A G, Mendonça Débora V C, Tavares Grasiele S V, Lage Daniela P, Ramos Fernanda F, Oliveira-da-Silva João A, Antinarelli Luciana M R, Machado Amanda S, Carvalho Lívia M, Carvalho Ana Maria R S, Salustiano Iorrana V, Reis Thiago A R, Bandeira Raquel S, Silva Alessandra M, Martins Vívian T, Chávez-Fumagalli Miguel A, Humbert Maria V, Roatt Bruno M, Duarte Mariana C, Menezes-Souza Daniel, Coimbra Elaine S, Leite João Paulo V, Coelho Eduardo A F, Gonçalves Denise U. Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.. Parasite immunology. 2020. DOI: 10.1111/pim.12784.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.